5-[(3,3,3-Trifluoro-2-hydroxy-1-arylprop yl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

Details for Australian Patent Application No. 2008328307 (hide)

Owner AstraZeneca AB Bayer Schering Pharma Aktiengesellschaft

Inventors Rehwinkel, Hartmut; Hassfeld, Jorma; Zollner, Thomas; Berger, Markus; May, Ekkehard; Schacke, Heike

Agent Davies Collison Cave

Pub. Number AU-A-2008328307

PCT Pub. Number WO2009/065503

Priority 07076019.4 22.11.07 EP

Filing date 8 November 2008

Wipo publication date 28 May 2009

International Classifications

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 49/233 (2006.01) Ketones

C07D 303/32 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/065503 Priority application(s): WO2009/065503

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008328311-Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

2008328304-Incontinence pant